Hundal R, Shaffer EA (2014) Gallbladder cancer: epidemiology and outcome. Clinical epidemiology. 6:99

PubMed  PubMed Central  Google Scholar 

Levy AD, Murakata LA, Rohrmann Jr CA (2001) Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 21(2):295–314. questionnaire, 549–555

Lazcano-Ponce EC, Miquel JF, Muñoz N et al (2001) Epidemiology and molecular pathology of gallbladder cancer. CA: Cancer J Clin 51(6):349–364

Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK (2019) Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 8(4):33

Article  PubMed  Google Scholar 

Abi-Rached B, Neugut AI (1995) Diagnostic and management issues in gallbladder carcinoma. Oncology 9:19–30

CAS  PubMed  Google Scholar 

Zhu AX, Hong TS, Hezel AF, Kooby DA (2010) Current management of gallbladder carcinoma. The Oncologist 15(2):168–181

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agrawal S, Gupta A, Gupta S, Goyal B, Siddeek RA, Rajput D, Chauhan U, Kishore S, Gupta M, Kant R (2020) Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of carcinoma gall bladder. J Carcinog 19:4

Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 75(S1):171–90

Article  CAS  PubMed  Google Scholar 

Rana S, Dutta U, Kochhar R, Rana SV, Gupta R, Pal R, Jain K, Srinivasan R, Nagi B, Nain CK, Singh K (2012) Evaluation of CA 242 as a tumor marker in gallbladder cancer. Journal of gastrointestinal cancer. 43(2):267–71

Article  CAS  PubMed  Google Scholar 

Haglund C, Lindgren J, Roberts PJ, Kuusela P, Nordling S (1989) Tissue expression of the tumour associated antigen CA 242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA19-9. Br J Cancer 60(6):845-51

Goetze TO (2015) Gallbladder carcinoma: prognostic factors and therapeutic options. World journal of gastroenterology. 21(43):12211

Article  PubMed  PubMed Central  Google Scholar 

Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A (2017) Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 23(22):3978–98

Article  PubMed  PubMed Central  Google Scholar 

Lin MS, Huang JX, Yu H (2014) Elevated serum level of carbohydrate antigen 19–9 in benign biliary stricture diseases can reduce its value as a tumor marker. International journal of clinical and experimental medicine. 7(3):744

PubMed  PubMed Central  Google Scholar 

Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ, Peng ZH (2014) Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World Journal of Gastroenterology: WJG. 20(14):4085

Article  PubMed  Google Scholar 

Acharya A, Markar SR, Matar M, Ni M, Hanna GB (2017) Use of tumor markers in gastrointestinal cancers: surgeon perceptions and cost-benefit trade-off analysis. Annals of surgical oncology. 24(5):1165–73

Article  PubMed  Google Scholar 

Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR (2020) CA 125 and ovarian cancer: a comprehensive review. Cancers. 12(12):3730

Björkman K, Mustonen H, Kaprio T, Kekki H, Pettersson K, Haglund C, Böckelman C (2021) CA 125: a superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA 242. Tumor Biology. 43(1):57–70